Q/C Technologies Overview
Q/C Technologies (QCLS) has a P/E ratio of -0.39, below the Healthcare sector average of 24.78.
Get informed when a big investor buys or sells
+ Follow-0.39
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for QCLS is -0.39. That is below the Healthcare sector average of 24.78. Investors often review this figure alongside Q/C Technologies's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, QCLS currently prints -0.39 for P/E ratio, while the sector average sits near 24.78. That is roughly 101.6% below the sector mean. Large gaps often invite a closer look at Q/C Technologies's growth, margins, and balance sheet.
A P/E ratio of -0.39 for Q/C Technologies is not 'good' or 'bad' on its own. Compare it with the peer average (24.78) and with QCLS's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting QCLS's P/E ratio (-0.39), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Q/C Technologies's P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
